Newton Bishop Julia A, Bishop D Timothy
Division of Genetic Epidemiology, Cancer Research UK, St James's Hospital, Leeds, UK.
Drugs Today (Barc). 2005 Mar;41(3):193-203. doi: 10.1358/dot.2005.41.3.892524.
The most common genetic determinants of skin cancer are the genes that control skin color so that the genes expressed as black skin are protective. Within the white population variants at the MC1R locus are shown to increase susceptibility, and recent evidence suggests that polymorphisms in the OCA2 gene interact to modify risk. Other as-yet-unidentified pigment genes may also play a role in susceptibility to melanoma. Thus MC1R variants are the most common low-penetrance melanoma-susceptibility genes so far identified. Other putative low-penetrance susceptibility genes have been explored using candidate gene approaches. Good candidates such as the DNA repair gene XRCC3 and polymorphisms of EGF have been studied but excluded. Other candidates such as BRAF polymorphisms and variants at the CDKN2A locus remain to be fully investigated. More progress has been made in identifying high-penetrance genes, however. The most common (and probably the most penetrant) susceptibility locus is the CDKN2A locus coding for two tumor suppressor proteins, p16 and p14ARF. Mutations at this locus that impact p16, p14ARF or both proteins all increase susceptibility to melanoma. Families inheriting such mutants are at increased risk of cutaneous melanoma, and the penetrance is increased by residence in sunny climates and co-inheritance of MC1R variants. Some families also appear to be at increased risk of pancreatic cancer, but the determinants of susceptibility to pancreatic cancer are not yet understood. Very rare families have germline mutations in the CDK4 gene which impact on the p16 binding site. There are other high-penetrance susceptibility genes, however, which remain undiscovered. There is evidence of one at 1p22. The Melanoma Genetics Consortium (www.genomel.org) continues to explore this and the genetic epidemiology of the CDKN2A locus.
皮肤癌最常见的遗传决定因素是控制肤色的基因,因此表现为黑色皮肤的基因具有保护作用。在白种人群中,MC1R基因座的变异显示会增加易感性,最近有证据表明,OCA2基因的多态性相互作用会改变风险。其他尚未确定的色素基因也可能在黑色素瘤易感性中起作用。因此,MC1R变异是迄今为止发现的最常见的低外显率黑色素瘤易感基因。其他假定的低外显率易感基因已通过候选基因方法进行了探索。像DNA修复基因XRCC3和表皮生长因子(EGF)的多态性等良好候选基因已被研究但被排除。其他候选基因,如BRAF多态性和CDKN2A基因座的变异仍有待全面研究。然而,在确定高外显率基因方面取得了更多进展。最常见(可能也是外显率最高)的易感基因座是编码两种肿瘤抑制蛋白p16和p14ARF的CDKN2A基因座。该基因座影响p16、p14ARF或这两种蛋白的突变都会增加黑色素瘤的易感性。继承此类突变体的家族患皮肤黑色素瘤的风险增加,而居住在阳光充足的气候地区以及MC1R变异的共同遗传会增加外显率。一些家族似乎患胰腺癌的风险也增加,但胰腺癌易感性的决定因素尚不清楚。非常罕见的家族在CDK4基因中有影响p16结合位点的种系突变。然而,还有其他未被发现的高外显率易感基因。有证据表明在1p22处存在一个。黑色素瘤遗传学联盟(www.genomel.org)继续探索这一点以及CDKN2A基因座的遗传流行病学。